Peter L. Salgo, MD: How do the biologics impact the asthma inflammatory pathway, and what is the targeted pathway for the treatment of asthma in the first place? Linda S. Cox, MD, FAAAAI, FACAAI, FACP ...

A recent study discovered more about the immunological mechanisms correlated with lung inflammation in some severe asthma patients, raising possibilities it may serve as a baseline for future research ...

Interleukin-9 is a pleiotropic cytokine associated with allergic inflammation 1 and is a therapeutic target in patients with asthma. Its expression and that of the interleukin-9 receptor are greater ...

Please provide your email address to receive an email when new articles are posted on . In recent years, we have made significant strides in our understanding of the pathogenesis of asthma. As a ...

asthma, lungs Authors review changes in the diagnosis, workup, and treatment of asthma in the 2022 GINA report. Some patients with asthma who lack evidence of type 2 inflammation are considered to ...

Asthma is a chronic inflammatory condition marked by an imbalance in the immune response within the airways. According to Lancet, asthma affects around 339 million people globally. While conventional ...

Shortness of breath, coughing, and respiratory infections. Childhood asthma, also known as asthmatic bronchitis, is one of the most common chronic diseases in children worldwide. But why does the ...

Asthma is a condition where the airways constrict, leading to breathing difficulties. People with asthma may use inhalers to deliver medication to the airways to avoid asthma attacks or to relieve ...

Asthma and chronic obstructive pulmonary disease (COPD) are both health conditions involving the respiratory system and can lead to difficulty breathing. There is some overlap between the two ...